These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12609795)

  • 1. IFN-gamma -positive immunostaining in psoriatic lesional keratinocytes--reply to the comments of McKenzie et al.
    Koga T; Duan H; Urabe K; Furue M
    Eur J Dermatol; 2003; 13(1):99. PubMed ID: 12609795
    [No Abstract]   [Full Text] [Related]  

  • 2. In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.
    Pasch MC; Timár KK; van Meurs M; Heydendael VM; Bos JD; Laman JD; Asghar SS
    J Pathol; 2004 Jul; 203(3):839-48. PubMed ID: 15221944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions.
    Higaki M; Higaki Y; Kawashima M
    J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
    Li X; Fan X; Zhang K; Yin G; Liu Y
    Eur J Dermatol; 2007; 17(5):392-6. PubMed ID: 17673382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma-induced 15-lipoxygenase-2 expression in normal human epidermal keratinocytes and a pathogenic link to psoriasis vulgaris.
    Setsu N; Matsuura H; Hirakawa S; Arata J; Iwatsuki K
    Eur J Dermatol; 2006; 16(2):141-5. PubMed ID: 16581564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of IFN-alpha immunostained cells in the psoriatic epidermis.
    McKenzie RC; Sabin E; Szepietowski JC; Em Howie S; Forsey RJ; Gracie JA
    Eur J Dermatol; 2003; 13(1):100-1. PubMed ID: 12609796
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
    Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
    J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    Arch Dermatol Res; 2004 May; 295(12):509-16. PubMed ID: 15024577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.
    Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB
    Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation.
    Ottaviani C; Nasorri F; Bedini C; de Pità O; Girolomoni G; Cavani A
    Eur J Immunol; 2006 Jan; 36(1):118-28. PubMed ID: 16323244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ localization of interferons in psoriatic lesions.
    Livden JK; Nilsen R; Bjerke JR; Matre R
    Arch Dermatol Res; 1989; 281(6):392-7. PubMed ID: 2480752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis: dysregulation of innate immunity.
    Bos JD; de Rie MA; Teunissen MB; Piskin G
    Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three decades of psoriasis research: where has it led us?
    Sabat R; Sterry W; Philipp S; Wolk K
    Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
    Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
    J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha.
    Yeoman H; Anderton JG; Stanley MA
    Immunology; 1989 Jan; 66(1):100-5. PubMed ID: 15493270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Shimizu T; Tada Y; Watanabe S
    Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
    Piskin G; Heydendael VM; de Rie MA; Bos JD; Teunissen MB
    Arch Dermatol Res; 2003 Mar; 294(12):559-62. PubMed ID: 12624782
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.